Jehanna Shaelah Erho, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 212 S Sullivan Ave, Fremont, MI 49412 Phone: 231-924-1212 |
Lindsay Ann Schmiedeknecht, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 212 S Sullivan Ave, Fremont, MI 49412 Phone: 231-924-1212 |
Dr. Nancy L Herta, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 212 S Sullivan Ave, Fremont, MI 49412 Phone: 231-924-3300 |
Arie J. Vanderweide, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 230 W Oak St, Suite 201, Fremont, MI 49412 Phone: 231-924-4200 Fax: 231-924-2001 |
News Archive
Celera Corporation today announced the publication of data reporting that elderly (over age 70) carriers of the KIF6 gene variant with prior vascular disease received significant benefit from pravastatin (Pravachol®) therapy. Previous research has shown that a variant of the KIF6 gene, a member of the molecular motor protein kinesin family, is associated with up to a 55% increased risk of primary and recurrent coronary heart disease (CHD) events in the placebo arms of the clinical trials, and that this increased risk is virtually eliminated with statin therapy.
Scientists from New Zealand and Australia have created the first three-dimensional image of a key protein involved in the development of blood and other cancers.
Researchers from the Regenstrief Institute and the Indiana University Center for Aging Research have identified the first biomarker that appears to be linked to the duration of delirium.
The Michael J. Fox Foundation for Parkinson's Research is teaming up with EHE International to raise awareness of the fight against Parkinson's disease. For the month of July, EHE International has kindly donated a 115-square-foot window space at 10 Rockefeller Plaza to showcase the many ways ordinary citizens can support the Foundation through its grassroots fundraising arm, Team Fox.
Mild cognitive impairment in patients with advanced cancer may affect the intensity of end-of-life treatment and promote decision-making by caregivers, rather than patients, show US study results.
› Verified 7 days ago